Patent · US Active

N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders

US9969738B2 · kind B2 · utility

2Cited by
2References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 28, 2014
Grant dateMay 15, 2018
Priority date—
Expiry dateMar 28, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel compounds of Formula Iand their use in therapeutic treatments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.